1. Cho JW, Jang EY, Woo HJ, Park YC, Kim SH, Hong KS, et al. Effects of renaming schizophrenia in Korea: from “Split-Mind Disorder” to “Attunement Disorder”. Psychiatry Investig. 2018; 15:656–662.
2. Ono Y, Satsumi Y, Kim Y, Iwadate T, Moriyama K, Nakane Y, et al. Schizophrenia: is it time to replace the term. Psychiatry Clin Neurosci. 1999; 53:335–341.
3. Chung KF, Chan JH. Can a less pejorative Chinese translation for schizophrenia reduce stigma? A study of adolescents’ attitudes toward people with schizophrenia. Psychiatry Clin Neurosci. 2004; 58:507–515.
4. Helgason L. Twenty years' follow-up of first psychiatric presentation for schizophrenia: what could have been prevented? Acta Psychiatr Scand. 1990; 81:231–235.
5. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry. 1986; 148:120–127.
6. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005; 162:1785–1804.
7. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry. 2000; 177:511–515.
8. Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S, et al. Early detection strategies for untreated first-episode psychosis. Schizophr Res. 2001; 51:39–46.
9. Wrigley S, Jackson J, Judd F, Komiti A. Role of stigma and attitudes toward help-seeking from a general practitioner for mental health problems in a rural town. Aust N Z J Psychiatry. 2005; 39:514–521.
10. Yingqiu G, Toshihide K, Seiji Y, Takeshi S, Masashi T, Shunzo K. Abnormal illness behavior and psychiatric disorders: a study in an outpatient clinic in Japan. Psychiatry Clin Neurosci. 2000; 54:447–453.
11. Compton MT, Esterberg ML. Treatment delay in first-episode nonaffective psychosis: a pilot study with African American family members and the theory of planned behavior. Compr Psychiatry. 2005; 46:291–295.
12. McGorry PD, Killackey EJ. Early intervention in psychosis: a new evidence based paradigm. Epidemiol Psichiatr Soc. 2002; 11:237–247.
13. Lee YS, Park IH, Park SC, Kim JJ, Kwon JS. Johyeonbyung (attunement disorder): renaming mind splitting disorder as a way to reduce stigma of patients with schizophrenia in Korea. Asian J Psychiatr. 2014; 8:118–120.
14. Lee YS, Kim JJ, Kwon JS. Renaming schizophrenia in South Korea. Lancet. 2013; 382:683–684.
17. Claire H, Sara EL, Graham T. Mental illness stigma, help seeking, and public health programs. Am J Public Health. 2013; 103:777–780.
18. Chan SKW, Li OWT, Hui CLM, Chang WC, Lee EHM, Chen EYH. The effect of media reporting of a homicide committed by a patient with schizophrenia on the public stigma and knowledge of psychosis among the general population of Hong Kong. Soc Psychiatry Psychiatr Epidemiol. 2019; 54:43–50.
19. Silverstein SM, Pozzo JD, Roche M, Boyle D, Miskimen T. Schizophrenia and violence: realities and recommendations. Crime Psychol Rev. 2015; 1:21–42.
20. Bo S, Abu-Akel A, Kongerslev M, Haahr UH, Simonsen E. Risk factors for violence among patients with schizophrenia. Clin Psychol Rev. 2011; 31:711–726.
21. Dickerson FB, Sommerville J, Origoni AE, Ringel NB, Parente F. Experiences of stigma among outpatients with schizophrenia. Schizophr Bull. 2002; 28:143–155.
22. Kim SW, Yoon JS, Lee MS, Lee HY. The analysis of newspaper-articles on psychosis. J Korean Neuropsychiatr Assoc. 2000; 39:838–848.
23. Kim SW, Kim SY, Yoo JA, Bae KY, Kim JM, Shin IS, et al. The stigmatization of psychosis in Korean newspaper articles. Korean J Schizophr Res. 2011; 14:42–49.
24. Thornicroft G, Rose D, Kassam A, Sartorius N. Stigma: ignorance, prejudice or discrimination. Br J Psychiatry. 2007; 190:192–193.
25. Franz L, Carter T, Leiner AS, Bergner E, Thompson NJ, Compton MT. Stigma and treatment delay in first-episode psychosis: a grounded theory study. Early Interv Psychiatry. 2010; 4:47–56.
26. Sibitz I, Amering M, Unger A, Seyringer ME, Bachmann A, Schrank B, et al. The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. Eur Psychiatry. 2011; 26:28–33.
27. McEvoy JP, Applebaum PS, Apperson LJ, Geller JL, Freter S. Why must some schizophrenic patients be involuntarily committed?; the role of insight. Compr Psychiatry. 1989; 30:13–17.
28. Toledo JR, Hughes H, Sims J. Management of non-compliance to medical regimen: a suggested methodological approach. Int J Health Educ. 1979; 22:232.
29. Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, et al. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry. 2001; 16:293–298.
30. Choi JH, Ahn SH, Wang SK, Chee IS, Kim JL, Lee SW. Prospective study to determine the efficacy of day hospital care to improve treatment adherence for hospitalized schizophrenic patients. J Korean Neuropsychiatr Assoc. 2013; 52:311–317.